Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 6.29 USD -4.84% Market Closed
Market Cap: 809.5m USD

EV/EBITDA
Enterprise Value to EBITDA

-60.3
Current
-69.8
Median
17.6
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-60.3
=
Enterprise Value
790m USD
/
EBITDA
-13.1m USD

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
14.1
2-Years Forward
EV/EBITDA
10.8
3-Years Forward
EV/EBITDA
7.3